🚨 Excited to chair the AI Applications in Human Health session at the MAQC 8th Annual Conference to make AI clinically relevant and reproducible. Transparency, reproducibility & reusability aren’t optional—they’re the foundation for trustworthy AI in healthcare. Join us: themaqc.org #AI #MAQC25

📣 Registration is OPEN for T-CAIREM’s 2025 Conference! 🗓️ Nov 14 2025 in Toronto! 🎤 The Evolution of #GenerativeAI 💡 Panels, debates & talks with leading #AI & #medicine experts 🔗 https://ow.ly/I7bO50WS6RC #AIinMedicine #AI #HealthAI #MedTech #AIinHealthcare

🔬 Can AI predict cancer-related symptoms before they happen? A new study between our team @pmcdi.bsky.social and Dr. Robert Grants team @pmresearch-uhn.bsky.social used ML on routine EHR data to forecast symptom deterioration in aerodigestive cancer patients. 👇 ascopubs.org/doi/10.1200/...

Thank you to everyone at @pmcdi.bsky.social and across @uhn.ca for bringing compassion, excellence, and heart into everything we do 💙 Together we are advancing discoveries and transforming the future of #CancerCare #TeamUHN #UHNGratitude @pmresearch-uhn.bsky.social @uhnresearch.ca

Congratulations to Drs. Cheryl Arrowsmith and John Dick on receiving the Canadian Cancer Society's Robert L. Noble Prize and Lifetime Contribution Prize, respectively! 🎉 These awards honour outstanding contributions and lasting impact in #CancerResearch.

🌏✈️ Taking @pmcdi.bsky.social innovation to Australia! 🎉Our Director of Design & Innovation, Mike Lovas, will be speaking at the #NSWCancerSummit2025 Check out Mike's talks and full lineup:🔗 cancer.nsw.gov.au/what-we-do/e... 📅 Aug 13–14 @pmresearch-uhn.bsky.social @uhnresearch.ca @uhn.ca

1/4 Last week was an exciting one for @pmresearch-uhn.bsky.social's CDI program at the AACR conference! This year’s focus: The transformative role of AI in oncology—from imaging innovations to foundation models shaping the future of #precisiononcology @theaacr.bsky.social #AACRai25

#AACRai25 cochairs Valentina Boeva and Benjamin Haibe-Kains adjourned the AACR Conference on AI and Machine Learning. We thank all of the chairs—including @marzyehghassemi.bsky.social and @bowang87.bsky.social—for developing an outstanding program. @valboeva.bsky.social @bhaibeka.bsky.social

Shoutout to @pmcdi.bsky.social Tran Truong and Mike Lovas for developing the Artificial Intelligence Patient Librarian — a chatbot that offers on-demand support for patients with metastatic breast cancer. A powerful example of how AI can help bridge gaps in support during a complex time 👏

Wow! Check this out-- really interesting work by researchers @pmresearch-uhn.bsky.social, featuring @pmcdi.bsky.social's Ale Berlin, who explored circular RNA (circRNA) and its role in the progression of #prostate and #lung cancer 🧬A big step in understanding tumour evolution

🚨From the @theaacr.bsky.social Annual Meeting: CDI’s @bhaibeka.bsky.social on the frontier of #AIinOncology-- virtual biopsies have the power to transform #cancercare 🧬Multimodal AI models can enable earlier and less invasive diagnostics 🔗 www.technologynetworks.com/cancer-resea...

🥊The #FightToEndCancer was a knockout success! Huge shoutout to CDI's Daniel Garcia for stepping into the ring and winning his match! 🏆He also crushed his fundraising goal in support of the Princess Margaret Cancer Foundation 💪 An unforgettable night💛#FTEC2025 @pmresearch-uhn.bsky.social @uhn.ca

🚨 A must-read! Huge congrats to the team & shoutout to CDI’s @bhaibeka.bsky.social on this fascinating paper introducing the #HealthDataNexus platform. A game-changer for secure, collaborative #AI research-setting a new standard for data-driven discoveries. Proud to see this innovation! 👏

Incredible work by CDI's own @bhaibeka.bsky.social and team — making it easier for cancer researchers to collaborate and share data is a huge step forward for accelerating discovery. Grateful for @ccsresearch.bsky.social supporting this important effort. 👏 #CancerResearch

June is #StrokeAwarenessMonth. As such, check out this recent publication in ATVB Journal from Dr. Kathryn Howe and team exploring endothelial cell communication with cells in atherosclerotic plaques (and AI had an adjunctive role in this work!). 👇🧵 www.ahajournals.org/doi/10.1161/...

🫁 Using #ArtificialIntelligence to Detect Changes in #Lung #Tumors with Greater Speed and Precision www.fraunhofer.de/en/press/res... #MedSky #AImedicine #AI #HealthAI #Healthcare #MedTech

New insights on brain tumour invasion Our study found that glioblastoma cells hijack normal brain development processes to infiltrate brain tissue, informing new ways to control cancer spread—a study led by Dr. Federico Gaiti in collaboration with Dr. Gelareh Zadeh. www.cell.com/developmenta...

1/3 It's Clinical Trials Week- an ideal moment to spotlight PMATCH: an AI-powered platform that will help automate the matching of eligible patients to the most suitable clinical trials based on their health data 🧬📊 #ClinicalTrials #AIinHealthcare #CareInnovation

1/2 📸🤖 Your selfie might reveal more than you think — including clues for personalized #CancerCare A new study featuring CDI’s @bhaibeka.bsky.social introduces FaceAge, an AI model that estimates biological age from photos Photos as biomarkers? The future of healthcare is here!

1/2: Grand Challenges thrive on collaboration! 🤝This year's CDI Grand Challenge proudly supports two innovative projects focused on #ResponsibleAI in #CancerCare. As part of this, we're thrilled to feature an exciting partnership with @uwaterloo.ca 🎉 @pmresearch-uhn.bsky.social @uhnresearch.ca

🎉 Thrilled to see CDI’s own @bhaibeka.bsky.social co-chairing the upcoming @theaacr.bsky.social Conference on AI and Machine Learning in Cancer Research! 🧬 An incredible lineup and an important conversation—don’t miss it!🗓️Register today: aacr.org/meeting/aacr... @pmresearch-uhn.bsky.social

#Artificialintelligence in #health information management: Using #AI for risk assessment in #medicine www.ama-assn.org/practice-man... #MedSky #AImedicine #AI #HealthAI #Healthcare #MedTech

1/4 📣 It's #PatientExperienceWeek and we’re proud to spotlight Digital Triage, a service developed by CDI with patients, @pmresearch-uhn.bsky.social staff, and leadership! This #innovation helps patients connect quickly with care teams—improving communication and outcomes @uhnresearch.bsky.social

During #PatientExperienceWeek, it's inspiring to see AI making a real difference💜 A new study shows how #AIchatbots can support patients with metastatic #BreastCancer by offering guidance during tough care decisions. Shoutout to CDI's very own Tran Truong & Mike Lovas— amazing work by the team! 👏

🎉Huge congrats to our CDI team on launching jarvAIs-an open-source Python package to standardize ML workflows jarvAIs Includes: 🧠 Analyzer – Data insights 📈 Trainer – Model training 🔍 Explainer – Prediction interpretability 🔗https://github.com/pmcdi/jarvais #AI #MachineLearning #Reproducibility

🎉On this #AdministrativeProfessionalsDay, we celebrate Rita McCurdy at CDI! ⭐ From organizing events, payroll, onboarding, and helping on key projects—amongst many other things, Rita keeps us running strong. We are incredibly lucky to have her! @pmresearch-uhn.bsky.social @uhnresearch.bsky.social

Proud to recognize CDI leaders Tran Truong, @bhaibeka.bsky.social for advancing Canada’s #cancerdata landscape🎉 Through @marathonofhope.bsky.social Data Committees, they’re building a more connected,high-quality ecosystem—fueling data-driven #innovation📊 shorturl.at/TnY8f @pmresearch-uhn.bsky.social

Looks like an amazing day at the #AIRCHECK Workshop 2025! 🤩 Big props to the folks who lead this event-- leading the charge on how AI/ML is shaping the future of drug discovery! 🙌 #AI #ML #Innovation #DrugDiscovery

🎉 Congrats to CDI’s @bhaibeka.bsky.social on the renewal of his Tier 2 Canada Research Chair in Computational #Pharmacogenomics! 🔬 His team is using #AI to predict tumor drug response & resistance — advancing treatment strategies.👏 A huge achievement! 🔗 bit.ly/3GpRlVl @pmresearch-uhn.bsky.social

🚨 Exciting news! UHN’s @pmresearch-uhn.bsky.social team has received Health Canada approval to start clinical trials for Porphysomes—innovative light-activated nanoparticles that enhance surgery and treat cancer. Congratulations to the team! 🎉 🔗 uhnresearch.ca/news/canadian-cancer-discovery

🚀A new study by our team explores clinician perspectives on #asynchronouscare for ovarian cancer patients on PARPi therapy. Findings highlight considerations like safety, patient preference, and willingness to innovate. 👀https://bit.ly/4j6w0ik @pmresearch-uhn.bsky.social @uhnresearch.bsky.social

Hello Bluesky, we're live and excited to be here!! We've been acquainting ourselves with this exciting new platform. Follow us to stay updated on all things @pmcdi.bsky.social @pmresearch-uhn.bsky.social, and the rapidly evolving world of #innovation and #digitalintelligence in healthcare 🚀🧠💡

Exciting news! Great opportunity for the best and brightest postdoctoral researchers, early-career scientists, and established stars to UHN - www.surveymonkey.com/r/MYVQPM9 @uhnresearch.bsky.social

🚨Big news!🚨 UHN just launched the Canada Leads 100 Challenge — aiming to recruit 100 top scientists to lead the future of health research and innovation 🌍🧬

Happy Oncology Nursing Day!🎗️ Today we shine a spotlight on the amazing oncology nurses at Princess Margaret Cancer Centre. Your commitment to excellence and compassionate care is inspiring. Thank you for everything that you do to improve cancer care 💙#OncologyNursingDay www.cano-acio.ca/page/OND